Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 11Terminated 7Active not recruiting 3Unknown 2Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 288Lymphoid 14Other solid neoplasm 11Thoracic 6Tumor-Agnostic 4Gynecologic 3Head & Neck 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Other 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 108Radiotherapy 45Docetaxel 44Radiotherapy, Intensity-Modulated 36Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13Blood Specimen Collection 13sintilimab 12nimotuzumab 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Oxaliplatin × Head & Neck × Clear all
NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase NA Unknown
12 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00363831 2010-07-28

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

The University of Hong Kong

Phase 2 Unknown
42 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡